We have 2 of 265 papers
We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.
Not the right person? Other researchers publish under this name.
Looking ahead, menin inhibitors may increasingly be incorporated into earlier lines of therapy, used as maintenance following allogeneic stem cell transplantation, and integrated into treatment approaches guided by measurable residual disease and evolving patterns of drug resistance.
We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.
